Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
YTE-001 by Bristar Immunotech Biotechnology for Hemophagocytic Lymphohistiocytosis: Likelihood of Approval
YTE-001 is under clinical development by Bristar Immunotech Biotechnology and currently in Phase I for Hemophagocytic Lymphohistiocytosis. According to GlobalData,...